IMNM - Immunome, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
14.15 2.35 (16.61%)	---	---	0.01 (0.06%)	-0.04 (-0.28%)	2.37 (16.94%)	0.18 (1.1%)	0.18 (1.1%)

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.5
Diluted EPS:: -0.5
Basic P/E:: -33.0
Diluted P/E:: -33.0
RSI(14) 1m:: 100.0
VWAP:: 16.5
RVol:: 1.133

Events

Period	Kind	Movement	Occurred At
Day	Price increase day	15.62 +1.47 (+10.39%)	Oct 15 14:31
1m	Price increase 1m	15.18 +0.16 (+1.07%)	Oct 15 11:31
1m	Price decrease 1m	14.87 -0.19 (-1.23%)	Oct 15 10:30
1m	Price increase 1m	15.04 +0.27 (+1.86%)	Oct 15 10:29
10m	Price increase 10m	15.04 +0.48 (+3.33%)	Oct 15 10:29